NMC
ORIC icon

NEA Management Company’s Oric Pharmaceuticals ORIC Stock Holding History

NEA Management Company’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.2M Hold
4,118,621
– – 2.97% 11
2025
Q4 		$33.7M Hold
4,118,621
– – 1.72% 13
2025
Q3 		$49.4M Hold
4,118,621
– – 2.71% 13
2025
Q2 		$41.8M Buy
4,118,621
+1,923,076
+88% +$12.9M 3.15% 8
2025
Q1 		$12.3M Buy
2,195,545
+629,464
+40% +$5.5M 0.94% 21
2024
Q4 		$12.6M Buy
1,566,081
+66,081
+4% +$606K 0.71% 21
2024
Q3 		$15.4M Hold
1,500,000
– – 0.84% 22
2024
Q2 		$10.6M Hold
1,500,000
– – 0.8% 24
2024
Q1 		$20.6M Buy
+1,500,000
New +$17.8M 1.28% 19

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NEA Management Company's ORIC Position: Q1 2026 in Review

NEA Management Company held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 4,118,621 shares worth $52.2M. The position accounts for 2.97% of the portfolio, ranked #11.

NEA Management Company first reported a position in ORIC in Q1 2024 and has held it in 9 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • NEA Management Company held 4,118,621 shares of Oric Pharmaceuticals worth $52.2M as of Q1 2026.
  • NEA Management Company left its Oric Pharmaceuticals share count unchanged in Q1 2026.
  • Oric Pharmaceuticals made up 2.97% of NEA Management Company's portfolio in Q1 2026, its #11 holding.
  • NEA Management Company first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.